Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

NCT01999725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety in Normal Volunteers

Interventions

DRUG: EDP-788
DRUG: Placebo

Sponsor

Enanta Pharmaceuticals, Inc